Williams Laura A 4

What Happened

Laura A. Williams, Ardelyx's Chief Patient Officer and interim Chief Medical Officer, disposed of a total of 8,176 shares on Feb 20, 2026 in two reported sell transactions tied to RSU vesting. She sold 7,192 shares at $5.87 for $42,181 and 984 shares at $5.71 for $5,622, totaling approximately $47,803. The transactions are reported as sales (code S).

Key Details

• Transaction date: 2026-02-20; Filed: 2026-02-23 (Form 4 accession 0001610717-26-000062)
• Sales: 7,192 shares @ $5.87 ($42,181) and 984 shares @ $5.71 ($5,622); total ≈ $47,803
• Reason/notable footnote: Footnote F1 indicates these were automatic sell-to-cover transactions executed upon RSU vesting solely to cover applicable withholding taxes.
• Shares owned after the transactions: Not specified in the provided filing excerpt.
• Transaction code: S (Sale). No late-filing flag indicated in the provided data.

Context

These sales were automatic tax-withholding dispositions of vested restricted stock units (RSUs), a routine administrative action that does not necessarily reflect the insider’s view of the company. For retail investors, purchases or independent open-market buys by insiders generally carry more weight as signals than automatic sell-to-cover transactions. For full details, review the issuer’s Form 4 (accession 0001610717-26-000062).